Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Viking Therapeutics (United States) | Researchclopedia

Back to institutions

Viking Therapeutics (United States)

San Diego, Californiacompany

8

Works

222

Citations

6

h-index

Top Research Topics

Cardiovascular Disease and Adiposity Diabetes Treatment and Management Bariatric Surgery and Outcomes

Top Researchers

Kathryn M. Albers

168 works9,153 citationsh-index: 52

Recent Research

Prevalence of Cardiovascular‐Kidney‐Metabolic Conditions Across Body Mass Index Categories: The Distinct Burden of Severe (Class <scp>III</scp> ) Obesity

Saif S. Rathore,Karen Chung,et al.

20260 citations

Pancreatic function and diabetes

Diabetes, Cardiovascular Risks, and Lipoproteins

Dialysis and Renal Disease Management

Thyroid Disorders and Treatments

Pharmacogenetics and Drug Metabolism

Chronic Kidney Disease and Diabetes

Adipokines, Inflammation, and Metabolic Diseases

Estrogen and related hormone effects

Adipose Tissue and Metabolism

Karen Chung Viking Therapeutics (United States)

148 works2,893 citationsh-index: 30

Hiroko Masamune Biogen (United States)

30 works2,479 citationsh-index: 12

Steven Schoenfeld Rabin Medical Center

23 works1,397 citationsh-index: 12

Karen Modesto Viking Therapeutics (United States)

41 works1,332 citationsh-index: 15

Rochelle M. Hanley Viking Therapeutics (United States)

19 works1,024 citationsh-index: 11

Weekly Subcutaneous <scp>VK2735</scp> , a <scp>GIP</scp> / <scp>GLP</scp> ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week <scp>VENTURE</scp> Study

Harold E. Bays,Phillip D. Toth,et al.

20260 citations

Abstract 4367152: VANQUISH-2: Phase 3, Randomized, Double-blind, Placebo-controlled, Trial of weekly subcutaneous administration of VK2735 in Obese or Overweight Adults with Type 2 Diabetes

Karen Modesto,Karen Chung,et al.

20251 citations

Abstract 4361241: Prevalence of cardiometabolic conditions across body mass index categories—the distinct burden of severe (class III) obesity

Saif S. Rathore,Karen Chung,et al.

20250 citations

CO107 Obesity Impact on Incidence of Chronic Comorbid Conditions

Karen Chung,Marianne Mancini,et al.

20250 citations

A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia

Jin Zhou,Lauren R. Waskowicz,et al.

201957 citations